Lifecome Biochemistry Co Ltd (002868) - Total Liabilities
Based on the latest financial reports, Lifecome Biochemistry Co Ltd (002868) has total liabilities worth CN¥1.49 Billion CNY (≈ $217.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Lifecome Biochemistry Co Ltd generate cash to assess how effectively this company generates cash.
Lifecome Biochemistry Co Ltd - Total Liabilities Trend (2012–2024)
This chart illustrates how Lifecome Biochemistry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Lifecome Biochemistry Co Ltd to evaluate the company's liquid asset resilience ratio.
Lifecome Biochemistry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Lifecome Biochemistry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CNB Financial Corporation
NASDAQ:CCNE
|
USA | $7.52 Billion |
|
Yueyang Xingchang Petro-Chemical Co Ltd
SHE:000819
|
China | CN¥1.17 Billion |
|
Evertz Technologies Limited
TO:ET
|
Canada | CA$195.65 Million |
|
Iress Ltd
AU:IRE
|
Australia | AU$294.06 Million |
|
Bangkok Airways Public Company Limited
BK:BA
|
Thailand | ฿36.18 Billion |
|
Evommune, Inc.
NYSE:EVMN
|
USA | $19.38 Million |
|
Lotus Technology Inc.
NASDAQ:LOT
|
USA | $3.12 Billion |
|
Minerals 260 Ltd
AU:MI6
|
Australia | AU$16.95 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Lifecome Biochemistry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Lifecome Biochemistry Co Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -13.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifecome Biochemistry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifecome Biochemistry Co Ltd (2012–2024)
The table below shows the annual total liabilities of Lifecome Biochemistry Co Ltd from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.52 Billion ≈ $221.87 Million |
-2.24% |
| 2023-12-31 | CN¥1.55 Billion ≈ $226.95 Million |
+142.12% |
| 2022-12-31 | CN¥640.56 Million ≈ $93.73 Million |
+19.42% |
| 2021-12-31 | CN¥536.38 Million ≈ $78.49 Million |
+164.80% |
| 2020-12-31 | CN¥202.56 Million ≈ $29.64 Million |
-12.52% |
| 2019-12-31 | CN¥231.55 Million ≈ $33.88 Million |
+273.18% |
| 2018-12-31 | CN¥62.05 Million ≈ $9.08 Million |
+2.45% |
| 2017-12-31 | CN¥60.56 Million ≈ $8.86 Million |
-39.02% |
| 2016-12-31 | CN¥99.32 Million ≈ $14.53 Million |
-35.31% |
| 2015-12-31 | CN¥153.54 Million ≈ $22.47 Million |
-22.93% |
| 2014-12-31 | CN¥199.22 Million ≈ $29.15 Million |
-12.03% |
| 2013-12-31 | CN¥226.45 Million ≈ $33.14 Million |
+5.37% |
| 2012-12-31 | CN¥214.92 Million ≈ $31.45 Million |
-- |
About Lifecome Biochemistry Co Ltd
Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, photovoltaic film products, etc.; veterinary drugs; and food preservatives. The company was founded in 2003 and is based in Pucheng, China.